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A B S T R A C T
The drug delivery through intraocular lenses (IOLs) allows the combination of cataract surgery act and
postoperative treatment in a single procedure. In order to prepare such systems, “clean” supercritical CO2
processes are studied for loading commercial IOLs with ophthalmic drugs. Ciproﬂoxacin (CIP, an
antibiotic) and dexamethasone 21-phosphate disodium (DXP, an anti-inﬂammatory drug) were
impregnated into foldable IOLs made from poly-2-hydroxyethyl methacrylate (P-HEMA). A ﬁrst pre-
treatment step was conducted in order to remove absorbed conditioning physiological solution.
Supercritical impregnations were then performed by varying the experimental conditions. In order to
obtain transparent IOLs and avoid the appearance of undesirable foaming, it was necessary to couple slow
pressurization and depressurization phases during supercritical treatments. The impregnation yields
were determined through drug release studies. For both drugs, release studies showdeep and
reproducible impregnation for different diopters.
For the system P-HEMA/CIP, a series of impregnations was performed to delimit the experimental
range at two pressures (80 and 200 bar) in the presence or absence of ethanol as a co-solvent for two
diopters (+5.0 D and +21.0 D). Increase in pressure in the absence of a co-solvent resulted in improved CIP
impregnation. The addition of ethanol (5 mol%) produced impregnation yields comparable to those
obtained at 200 bar without co-solvent. A response surface methodology based on experimental designs
was used to study the inﬂuence of operating conditions on impregnation of IOLs (+21.0 D) in the absence
of co-solvent. Two input variables with 5 levels each were considered; the pressure (80–200 bar) and the
impregnation duration (30–240 min). CIP impregnation yields ranging between 0.92 and 3.83 mgCIP/
mgIOLwere obtained from these experiments and response surface indicated the pressure as a key factor
in the process.
The DXP impregnation in P-HEMA was higher than CIP at all the tested conditions (8.50–14.53 mgDXP/
mgIOL). Furthermore, unlike CIP, highest DXP impregnation yields were obtained in the presence of
ethanol as a co-solvent (5 mol%). NMR spectroscopy was performed to conﬁrm complete removal of
ethanol in the co-solvent-treated IOLs.
1. Introduction
Cataract is the most common cause of blindness and severe
visual impairment worldwide, and its surgery is the most
frequently performed ocular procedure. The number of patients
with cataract is continuously increasing (Eperon et al., 2013), and
currently about 2 million people have their cataractous lenses
removed and replaced with an intraocular lens (IOL) each year
(Eperon et al., 2008). The surgery involves implantation of an
artiﬁcial intraocular lens to replace opaciﬁed (damaged) natural
crystalline lens (Eperon et al., 2013). It is considered safe, however,
postoperative infections including endophtalmitis (Parsons et al.,
2005; Barry et al., 2006), (rare but potentially devastating
condition) and posterior capsular opaciﬁcation (less serious but
common) (Wright et al., 1988; Miyake et al., 2000; Simone and
* Corresponding authors. Fax: +33 4 42 90 85 15.
E-mail addresses: abir.gch@hotmail.fr, abir.bouledjouidja@etu.univ-amu.fr
(A. Bouledjouidja), yasmine.masmoudi@univ-amu.fr (Y. Masmoudi),
elisabeth.badens@univ-amu.fr (E. Badens).
Page 1 sur 15
Whitacre, 2001; Yorio et al., 2008) are known to regularly occur in
patients.
To prevent short- and long-term complications, a concentrated
solution of anti-inﬂammatory or antibiotic drugs is injected
(subconjunctival, topical, intracameral or intravitreal) in the eye
after cataract surgery (Parsons et al., 2005). However, the efﬁcacy
of this treatment is limited either due to poor drug bioavailability
across the blood-ocular barriers (McGhee et al., 2002) or serious
side effects (Eperon et al., 2008).
Signiﬁcant advances have been made in developing new
treatments for the prevention of ocular risks following cataract
surgery. The advent of new technologies opens the door to new
controlled drug delivery systems to prevent postoperative
complications. The ability of these systems to deliver drugs at
predetermined rates for predeﬁned periods of time in the speciﬁc
targeted site have been used to overcome the shortcomings of
conventional techniques. Most of these proposed ophthalmic drug
delivery systems are polymer-based and are either of a reservoir or
a matrix type (Yorio et al., 2008).
The development of drug incorporated IOLs allows the
combination of the cataract surgery and postoperative treatment
in a single procedure (Anderson et al., 2009). It can provide a
prolonged intraocular release of anti-inﬂammatory and antibiotic
agents after surgery leading to improved efﬁcacy, reduced toxicity,
and better patient compliance (Uhrich et al., 1999).
Several manufacturing processes have been developed to
produce polymeric (biocompatible or biodegradable) drug delivery
systems including molecular imprinting (Alvarez-Lorenzo and
Concheiro, 2004; Venkatesh et al., 2007), ion ligands binding
(Uchida et al., 2003; Sato et al., 2005), soaking into liquid (Karlgard
et al., 2003; Aqil and Gupta, 2012) among others (Li et al., 2007).
Nevertheless, these conventional techniques have some disadvan-
tages such as; high processing temperatures that can deteriorate
thermosensitive Active Pharmaceutical Ingredients (API), or the
use of organic solvents that must be removed through numerous
puriﬁcation steps to meet FDA’s requirements (Champeau et al.,
2015a).
To overcome the above-mentioned limitations, the supercritical
ﬂuid assisted impregnation has proven to be an alternative green
process for pharmaceutical products (Pasquali and Bettini, 2008).
The activity of the drug molecules can be preserved notably
because supercritical carbon dioxide (scCO2) processing is
performed at moderate temperatures (Sun, 2002).
The sorption of scCO2 in a large number of natural and synthetic
polymers permits impregnation of hydrophobic molecules with-
out or with a minimal use of a co-solvent. The major advantages of
supercritical impregnation include; tunable solute loading and
impregnation depth by slight changes in processing conditions.
Moreover, residual organic solvent free end-products are obtained
since scCO2 is released spontaneously as a gas during depressuri-
zation (De Souza et al., 2014).
Supercritical impregnation techniques have been successfully
applied to polymer processing among other applications to
develop drug delivery systems (Üzer et al., 2006 López-Periago
et al., 2009; Kikic and Vecchione, 2003; Masmoudi et al., 2011).
Drug impregnation of biocompatible or biodegradable polymers
requires the use of a vector phase to solubilize and carry the drug
component within the impregnation support (López-Periago et al.,
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Tg Glass transition temperature
Mt Cumulative amount of drug released at time t
M1 Cumulative amount of drug released at inﬁnite
time
k Kinetic constant
n Release exponent representing release mecha-
nism
m0IOL Initial mass of dry IOL
Fig. 1. Interactions governing supercritical impregnation.
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swells the polymer matrix, thus increasing the free volume among
polymer molecules. This enhances the mass transfer of the ﬂuid
phase containing the drug within the polymer matrix (Kazarian
and Martirosyan, 2002). Supercritical impregnation often leads to
molecular dispersion of the drug within the polymer (with a
homogeneous distribution) that is also known to improve the
dissolution kinetics of the drug (Yu et al., 2011). Moreover, this can
be carried out either in a batch mode or in a continuous mode using
one or two autoclaves.
In scientiﬁc literature, the works of Sand (1986) and Berens
et al. (1992) are often used as the ﬁrst references for the application
of the supercritical ﬂuid impregnation in polymeric materials.
Alessi et al. (1998) and Kikic and Sist (1998) had then showed the
possibility of using supercritical impregnation in the development
of polymeric drug delivery systems.
In general, the supercritical impregnation process involves the
following three steps:
1. The solubilization of the solute in the scCO2 and swelling of the
polymer by CO2 sorption.
2. Drug partition of the solute between the CO2 rich phase and the
polymer.
3. CO2 release and entrapment of the solutes within the polymer.
Different interactions are involved in scCO2 impregnation
process as presented in Fig. 1.
The supercritical impregnation can take advantage from the
sorption of scCO2 in polymers leading to their swelling and
plasticization (Kikic and Vecchione, 2003). It is possible to tune the
degree of polymer swelling by modifying the sorption degree while
varying scCO2 density. The process of diffusion of the drug within
CO2-swollen polymer can therefore be controlled to obtain desired
amount of drug into the polymer support (Kazarian et al., 1998).
The ability of CO2 to interact with the functional groups in the
molecule polymer (Kazarian, 2000) results in enhanced segmental
and chain mobility and an increase in interchain distance (Kazarian
and Martirosyan, 2002) leading to the depression in glass
transition temperature (Tg) (from 0.5 to 2.8 C/bar, e.g., 1.2 C/bar
for PMMA (Tomasko et al., 2003)).
Berens et al. (1992) demonstrated that impregnation of di-
methyl phthalate into polymers such as PMMA, PolyVinyl Chloride
(PVC), PolyCarbonatye (PC) and PolyVinyl Alcohol (PVA) can be
enhanced in scCO2-swollen polymers. Similarly, Kazarian et al.
(1997,1999) showed that CO2 acts as a kind of ‘molecular lubricant’,
making it easier for polymeric chains to slip over one another, thus
accelerating the solute diffusion.
Various physico-chemical properties including solubility of
drug in supercritical phase are crucial for the development of drug
delivery systems using scCO2. The solubility controls the amount of
drug component that can be carried by the ﬂuid phase and has
been already reviewed in the literature (Škerget et al., 2011; Gupta
and Shim, 2006). Solutes with high solubility in scCO2 can be easily
delivered within the polymeric matrix. Meanwhile, studies show
that the impregnation of low CO2-philic API could also be achieved
if it has a strong afﬁnity for the polymer leading to favorable
partitioning toward the polymer matrix (Kazarian et al., 1998).
Furthermore, higher drug inclusion can be achieved by the
addition of small quantities of polar co-solvent to the scCO2 phase
to improve the solubility of solid compound in the media. A
favorable partitioning of the drug toward polymer is also
important for satisfactory impregnation of given API along with
its sufﬁcient solubility in the media. Kazarian and Martirosyan
(2002),Kazarian (2004) and Lora and Kikic (1999) proposed two
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The mechanism based on the partition coefﬁcient relies on the
afﬁnity of a solute in a ﬂuid phase toward the polymer due to the
speciﬁc interactions such as van der Waals, etc. This approach can
explain the impregnation of compounds with low solubility in
scCO2 (Kazarian et al., 1998). In this mechanism, the solute is
believed to be molecularly dispersed within the polymer and the
process is expected to complete when an equilibrium concentra-
tion is achieved in the matrix (Kazarian, 2004). The second
mechanism involves deposition of a solute into the polymeric
matrix when CO2 leaves swollen polymer during depressurization
(Berens et al., 1992). During the impregnation process, the scCO2
solubilizes the drug and swells the polymer. The solute enriched
ﬂuid phase is allowed to diffuse inside the matrix for a
predetermined period followed by a depressurization step. The
solubility of the drug in scCO2 suddenly decreases and simulta-
neous CO2 expulsion from the polymer results in solute entrap-
ment inside the matrix at this stage. This approach is especially
effective for solutes with high solubility in scCO2 (Kazarian, 2004;
Lora and Kikic, 1999).
One of the major advantages of supercritical impregnation is
the possibility of adjusting the impregnation efﬁcacy by ‘tuning’
the properties of scCO2. Different operational parameters of the
process can be varied such as the pressure, temperature,
impregnation duration, process mode (batch or semi-continuous),
CO2 ﬂow rate in a semi-continuous mode, solute concentration in
the supercritical phase, the use (nature and amounts) of a co-
solvent as well as the depressurization rate.
The supercritical impregnation for ocular applications has been
widely discussed in the scientiﬁc literature and known to result in
enhanced drug loading and controlled delivery of an API. Table 1
reviews the publications on scCO2 impregnation applied for the
development of polymer-based therapeutic ophthalmic articles.
Supercritical impregnation was shown to be more efﬁcient and
tunable than conventional soaking methods (Braga et al., 2011;
González-Chomón et al., 2012) while requiring shorter processing
durations. The supercritical processing mode also has inﬂuence on
the impregnation efﬁciency. For example, batch processes are
known to provide higher impregnation yields in short durations
with homogeneous distribution of a drug within polymer
compared to semi continuous process (Duarte et al., 2008).
Furthermore, processing with scCO2 is proven to retain critical
functional properties such as glass transition temperature,
transmittance, oxygen permeability (Costa et al., 2010b; Yañez
et al., 2011; Braga et al., 2011; González-Chomón et al., 2012) and
contact angle of contact lenses (Costa et al., 2010b; Yañez et al.,
2011). The transparency of ocular articles like contact or
intraocular lenses is very important, hence, foaming phenomenon
has to be imperatively avoided could simply be achieved by slow
depressurizations (Masmoudi et al., 2011).
The aim of the present work was to study the impregnation of
dexamethasone 21-phosphate disodium (DXP) and ciproﬂoxacin
(CIP) in intraocular lenses (IOLs) using scCO2. DXP
(C22H28FNa2O8P), a synthetic adrenal corticosteroid with potent
anti-inﬂammatory properties is used in eye, ear and systemic
formulations. CIP (C17H18FN3O3) is a synthetic antibiotic of second-
generation ﬂuoroquinolone and commonly prescribed for the
treatment of eye infections including corneal ulcers (Pellegrino
et al., 2008). Commercially available foldable IOLs made of P-HEMA
were used in this work. The ability of these lenses to absorb water
assists oxygen supply to cornea and requires only 2–3 mm incision
in comparison to 10–12 mm for non-foldable lenses (Aquavella and
Rao, 1987; Florkey et al., 2003). A number of parameters such as
pressure, temperature, pressurization/depressurization rate, co-
solvent requirement and impregnation duration were investigated
to achieve optimum and homogeneous distribution of both drugs
in P-HEMA IOLs.
A pretreatment step was necessary to dry P-HEMA lenses and to
obtain a reproducible initial state for drug impregnation. The IOLs
were dried using two different modes; in an oven and with scCO2.
Thermal analysis was performed to verify the presence of water
and to establish appropriate drying method. For all experiments
thereafter, IOLs were initially dried in an oven at 90 C before the
impregnation process.
Ethanol was chosen as a co-solvent and employed at 5% (molar)
in order to increase drugs solubility in the scCO2 and to enhance
the polymer swelling (Bertucco and Vetter, 2001). It can
signiﬁcantly improve the polarity of the ﬂuid phase since it has
a complet miscibility in scCO2. Ethanol is also a ‘class 3’ solvent
according to the FDA which marks it as comparatively safe for
human health (Champeau et al., 2015a). NMR analyses on scCO2-
treated IOLs was performed to determine the presence of residual
solvent.
In vitro drug release studies in simulated aqueous humor were
conducted on all drug-incorporated lenses. The drug release was
quantiﬁed using UV–vis spectroscopy and impregnation yields
were calculated for both CIP and DXP.
2. Materials and methods
2.1. Materials
Supercritical impregnations were performed on Tecsoft fold-
able acrylic intraocular lenses (FLEX IOLs); supplied by ‘The Fred
Hollows Intraocular Lens’ (Nepal). The IOLs of three diopters
(+5.0 D, +21.0 D and 32.0 D) used in this work are commercially
available and manufactured from the derivatives of poly(2-
hydroxyethyl methacrylate) (P-HEMA). The P-HEMA IOLs are
supplied soaked in a physiological solution. The properties of the
IOLs as reported by the supplier are summarized in Table 2 and a
photograph of the IOL as well as the chemical formula of the
polymer is presented in Fig. 2.
All other chemicals used in this work are listed in Table 3 and
the skeletal formulas of both drugs are presented in Fig. 3.
2.2. Methods
2.2.1. IOLs pretreatment
The P-HEMA IOLs are supplied pre-soaked in a physiological
solution. They absorb a certain quantity of this solution due to their
hydrophilic nature which makes them ﬂexible under ambient
pressure and temperature. These wet IOLs were dried following
two different methods; in an oven and using supercritical CO2.
The drying in the oven was performed at two temperatures
(40 and 90 C) for 10 days.
The drying of IOLs with scCO2 was carried out in a batch mode
under 80 bar for 30 min and 140 bar 135 min. Other parameters i.e.,
temperature (35 C), pressurization rate (CO2 ﬂow rate of 250 g
h1) and depressurization rate (2 bar min1) were kept constant
for these experiments.
2.2.2. IOLs impregnation
A schematic diagram of the experimental high-pressure set-up
is shown in Fig. 4. It is mainly composed of a 125 ml high-pressure
Table 2
Properties of foldable IOLs.
P-HEMA (FLEX)
Dioptric power (D) +5.0 +21.0 +32.0
Optical diameter (mm) 6 5.9 5.8
Overall diameter (mm) 13.5 13 12.5
Convexity Biconvex Biconvex Biconvex
Page 4 sur 15
cell (Top Industrie S. A., France) and a high-pressure liquid CO2
pump (Milton Roy, France). The autoclave is positioned on a
magnetic stirrer to ensure fast solubilization and homogenization
of the API and immersed in a thermostat bath to regulate its
temperature.
Supercritical impregnations were carried out in a batch mode
where IOLs (2 per batch) were placed on an aluminum support
inside the high-pressure cell to separate them from the stirrer bar.
A known quantity of the API was introduced in the autoclave and
was protected by a frit ﬁlter to prevent any contamination of the
IOLs surface. For the impregnation with a co-solvent, a predeﬁned
quantity of ethanol was ﬁrst placed in the bottom of the autoclave
and IOLs support was positioned carefully to prevent any contact
with the lenses. The high-pressure vessel was closed and heated to
35 C and then ﬁlled with CO2. For this purpose, CO2 was ﬁrst
liqueﬁed through a cooling unit and then pressurized and supplied
to the system after heating by a feed pump until desired pressure
was reached. The ﬂuid phase containing API was allowed to diffuse
within the IOLs for a pre-determined impregnation duration. The
system was then slowly depressurized (2 bar min1) in order not to
damage the IOLs and to avoid foaming (Masmoudi et al., 2011).
For impregnations carried out using a co-solvent; a supple-
mentary CO2 washing step (1 h) was carried out before depressur-
ization to remove ethanol and avoid its condensation inside the
autoclave.
2.2.3. Experimental design and response surface methodology
Response surface methodology (RSM) consists of a group of
mathematical and statistical techniques that can be used to deﬁne
the relationships between the response and independent varia-
bles. In RSM, an empirical mathematical model is postulated and a
suitable experimental design is performed to estimate required
coefﬁcients. This model, once validated can be used to predict the
response in the whole experimental domain with good precision
(Baş and Boyacı, 2007).
For supercritical impregnation of P-HEMA IOLs, a two factors
central composite design with 9 individual design points in a
spherical domain was adopted (Table 4). The variables studied
were pressure (in bar, x1) and impregnation duration (in min, x2).
Other variables of the process; temperature (35 C) and depres-
surization rate (2 bar min1) were kept constant. The experiments
of the planned design were carried out in the absence of a co-
Fig. 2. P-HEMA (a) aspect of non treated IOL and (b) skeletal formula.
Table 3
Chemical compounds references.
Chemical Supplier Purity% CAS Batch No.
Dexamethasone 21-phosphate disodium Sigma–Aldrich (France) 98 50-02-2 MKBS2101V
Ciproﬂoxacin Sigma–Aldrich (France) 98 85721-33-1 BCBM7969V
Carbon dioxide Air liquid (France) 99.7
Ethanol Groupe MERIDIS (France) 99.8 210.05.14
Monobasic potassium phosphate Sigma–Aldrich (France) 99.0 7778-77-0 BCBM7799V
Disodium hydrogenphosphate Sigma–Aldrich (France) 99.0 75588-79-4 A0320538
Fig. 3. Structural formula of (a) ciproﬂoxacin and (b) dexamethasone 21-phosphate disodium.
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solvent. Response or dependent output variable (Y) studied was the
impregnated amount quantiﬁed through release studies. Experi-
ments in the given domain were repeated to verify the validity of
the stated model.
A second order polynomial model as presented in Eq. (1) was
postulated to capture the possible nonlinear effects and curvatures
in the studied domain:












where xj (j = 1,2, . . . k) is the undimensional variables and b0, bi, bii
and bij are regression coefﬁcient for intercept, linear, quadratic and
synergic, respectively. The coefﬁcients were estimated using
multilinear regression from the results of studied responses. The
calculations were performed with the Nemrod-W software (LPRAI,
Marseille, France) developed for building and processing experi-
mental design.
For validation of the model suitability, several techniques were
used i.e., residual analysis, ANOVA (ANalysis Of VAriance) and
prediction error sum of squares residuals (especially the coefﬁcient
of determination, R2). After validation, this model was used to
calculate the response all over the domain.
2.2.4. Differential scanning calorimeter (DSC) analysis
Thermal analyses of various pretreated and impregnated IOLs
were performed in a TA Q2000 DSC. Samples were accurately
weighed (18–20 mg) into aluminum pans and thermograms were
obtained over a temperature range of 50–300 C. Each sample was
exposed to heat-cool-heat cycle with a heating or cooling rate of
10 C/min. DSC analysis was performed on samples before and after
pretreatment and drug impregnation to identify possible changes
in the thermal properties of IOLs. The DSC measurements were
duplicated.
2.2.5. Nuclear magnetic resonance (NMR) analysis
Solid-state NMR spectroscopy was used for quantifying residual
solvent content in the impregnated IOLs. 13C NMR spectra were
obtained using a Bruker Avance 400 MHz spectrometer consisting
Bruker double-channel probe operating at a resonance frequency
of 106 MHz. 20 mg of each sample was placed into zirconium
dioxide rotors with 4 mm outer diameter. The rotors were
equipped with two PTFE spacers and spun at a Magic Angle
Spinning rate of 10 kHz.
The cross polarization (CP) technique (Schaefer and Stejskal,
1976) was applied with a ramped 1H-pulse starting at 100% and
decreasing until 50% during the contact time of 2 ms to circumvent
Hartmann–Hahn mismatches (Cook et al., 1997; Peersen et al.,
1993). A dipolar decoupling GT8 pulse sequence (Gerbaud et al.,
2003) was applied during the acquisition time to improve the
resolution. In order to obtain a good signal-to-noise ratio in the 13C
CPMAS experiment, 8 K scans were accumulated at room
temperature using a delay of 3 s. The 13C chemical shifts were
referenced to tetramethylsilane and calibrated with the glycine
carbonyl signal set at 176.5 ppm.
2.2.6. Drug release study
In vitro drug release studies were carried out in simulated
aqueous humor (pH of 7.2). It was prepared by mixing 9.08 g L1 of
a monobasic potassium phosphate (KH2PO4) and 9.47 g L
1 of a
disodium hydrogenophosphate (Na2HPO4) solutions in a volume
ratio of 0.285/0.715 respectively.
Prior to release studies, IOLs were washed with 5 ml of simulated
aqueous humor for 3 min under stirring to remove any drug
deposited at the surface. The rinsing solution was analysed
spectrophometrically for CIP and DXP content at 248 and 277 nm
respectively using Jenway 6715 UV/Vis. Drug concentrations in
washing solution was found to be too low for UV–vis analysis.
Release studies were conducted by immersing impregnated
IOLs in 5 ml of simulated aqueous humor (pH of 7.2) under stirring
in a closed vessel at 37 C. An aliquot of 0.4 ml was collected every
day for 60 days and CIP or DXP release was quantiﬁed at 248 nm or
277 nm respectively (Jenway 6715 UV/Vis). Aliquots were then
returned to the release vessel to maintain the initial volume. The
drug release from both IOLs impregnated in the same batch was
studied separately in order to verify the homogeneity and
reproducibility of the process.
Fig. 4. Supercritical impregnation set-up: (1) CO2 cylinder, (2) cooling bath, (3) high pressure liquid pump, (4) heating bath, (5) high pressure cell, (6) support, (7) magnetic
bar, (8) magnetic stirrer, (9) thermostat bath, (10) depressurization valve, (11) solvent trap.
Table 4
Variables (factors) used for central composite design.
Independent variables Symbols Codes-variable levels
1 0 +1
P (bar) X1 80 140 200
timp (min) X2 30 135 240
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2.2.7. Modeling of drugs release from P-HEMA IOLs
There are a large number of articles on drug release modeling
from matrix systems starting from the pioneering work of Higuchi
(1967) to recent detailed models of Galdi and Lamberti (2012).
Ritger and Peppas (1987a) suggested an empirical equation which
can be used to analyze low drug release (below 60%) from non-




where Mt and M1 represent the cumulative drug released at times
t and inﬁnity respectively. k is a kinetic constant that incorporates
structural/geometric characteristic of a delivery system (polymer +
drug) and n is designated as an exponent representing the release
mechanism.
Eq. (2) can also be used for the analysis of controlled release
systems based on moderately swelling polymers (e.g., systems
based on hydroxypropyl methyl cellulose, poly(vinyl alcohol), poly
(2-hydroxyethyl methacrylate), etc.). Therefore, this equation was
used to model drug release from IOLs as overall swelling of these
systems was less than 25%. In this work, the release constant k and
release exponent parameter n were ﬁtted using Eq. (2) to the ﬁrst
60% release of the impregnated drugs from IOLs.
2.2.8. Impregnation yields
The impregnated amounts were determined through release
studies and deﬁned as cumulative mass release of the drug after
reaching to a constant value. The impregnation yield was





where mimp is mass of impregnated API and m0IOL is initial mass of
dry IOL.
3. Results and discussion
3.1. IOLs foaming
Foaming due to sorption and release of scCO2 from a polymeric
matrix is very common. Hence, it was important to understand the
effect of pressurization and depressurization rates on the optical
properties of P-HEMA IOLs.
In our experimental conditions, rate of pressurization was
observed to be a signiﬁcantly important factor in controlling the
integrity of IOLs. In order to elucidate this phenomenon, inﬂuence
of the pressurization rate of scCO2 at three different ﬂow rates of
slow (250 g h1), intermediate (650 g h1) and fast pressurization
(>900 g h1) was studied in a batch mode at ﬁxed pressure
(200 bar), temperature (35 C) and duration (2 h). Based on
previous studies on rigid PMMA IOLs, the depressurization was
carried out under controlled rate of 2 bar min1 (Masmoudi et al.,
2011).
The scCO2 treatment of IOLs with pressurization rates of 650
and 900 g h1 resulted in foaming and loss in the optical properties
of the IOLs as illustrated in Fig. 5.
Similar loss in optical properties was also observed for samples
treated at lower pressure (80 bar) and slower depressurization rate
(0.7 bar min1) with or without a co-solvent for pressurization
rates of 650 and 900 g h1.
For the considered application of IOLs, foaming even with few
bubbles has to be imperatively avoided. This was achieved by
controlled pressurization at 250 g h1 coupled with a depressuri-
zation rate of 2 bar min1. Samples treated at abovementioned
conditions resulted in transparent IOLs at both 80 and 200 bar and
in the presence or absence of a co-solvent (Fig. 6).
Generally in the literature, foaming in polymers is reported to
occur during depressurization phase. This is due to the quick
desorption of gas from a matrix during rapid depressurization. This
fast release of CO2 induces nucleation and growth of bubbles until
the pressure reaches a point where foamed structure freezes
(Kazarian, 2004). The number and size of the created bubbles
depend on the pressure, temperature and impregnation duration
in addition to the depressurization rate (Goel and Beckman, 1994;
Reverchon and Cardea, 2007; Xu et al., 2007).
In our work, even in slow depressurization conditions, foaming
was observed for rapid pressurization phases which suggests that a
brisk CO2 sorption in P-HEMA lenses promotes sudden swelling
and subsequent deformation. All scCO2 treatments of IOLs (pre-
treatments as well as impregnations) were performed at a CO2 ﬂow
rate of 250 g h1 from hereon to avoid foaming and loss of optical
properties during processing.
3.2. IOLs pretreatment
Since the hydrophilic P-HEMA IOLs were supplied pre-condi-
tioned in a physiological solution, a preliminary drying step was
necessary to extract absorbed water and to obtain reproducible
initial conditions for impregnation. At ﬁrst, the inﬂuence of drying
mode (oven and scCO2) was studied to understand the suitability of
Fig. 5. Inﬂuence of the pressurization rate on the visual aspect of some IOLs; (a) non treated IOL; (b) IOL treated with scCO2 at 200 bar with a pressurization rate of 650 g h
1;
(c) IOL treated at 200 bar with a rapid pressurization rate of 900 g h1.
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these methods and to determine required temperature and
pressure for efﬁcient drying.
The IOLs were dried in an oven at two temperatures (40 and
90 C) and DSC analyses were performed to determine the Tg of
IOLs after this procedure. DSC analyses of the IOLs dried in an oven
at 40 C and 90 C showed a Tg of 113 C and 121 C, respectively
(pre-treatments as well as impregnations). This can be attributed
to the efﬁcient removal of water from IOLs at higher temperature.
Absorbed water in a polymeric matrix acts as a plasticizer which
leads to decreased Tg as evident by the samples dried at 40 C. The
temperature of 90 C was required for the removal of water
efﬁciently from P-HEMA IOLs.
DSC analyses of the IOLs dried with scCO2 at (80 bar, 30 min)
and (140 bar, 135 min) show a Tg of respectively 119 and 121 C,
respectively (Table 5). Once again, the increase of Tg with increase
in the pressure and drying time can be explained by the efﬁcient
removal of water from P-HEMA IOLs.
A Tg of 121 C for IOLs dried by both oven (90 C) and scCO2
(140 bar, 35 C for 135 min) methods along with the same weight
loss (0.21 gwater/gdried IOL) indicated removal of most of the water at
these conditions.
3.3. Supercritical impregnation of IOLs
3.3.1. Ciproﬂoxacin impregnation
3.3.1.1. Preliminary impregnations. IOLs were dried at 90 C in an
oven before preliminary impregnation experiments. The drug
impregnations were performed with or without co-solvent at
80 and 200 bar on IOLs with two different diopters (+5.0 D and
+21.0 D).
The impregnation results presented in Table 6 are expressed in
term of the impregnated mass of ciproﬂoxacin in IOL (mcip imp) and
the impregnation yield (yimp).
In the absence of co-solvent, a pressure increase from 80 to
200 bar led to improved CIP impregnation. The drug impregnation
for diopter +5.0 D increased from 0.92 to 3.45 mgdrug/mgIOL.
Similarly, an increase from 0.95 to 2.86 mgdrug/mgIOL for diopter
+21.0 D. This improvement in CIP loading can be attributed to the
concurrent increase in the solubility of the drug and polymer
swelling due to CO2 sorption (Yu et al., 2011; Braga et al., 2008;
Guney and Akgerman, 2002; Champeau et al., 2015b). The addition
of ethanol as a co-solvent in the procedure resulted in signiﬁcant
increase in drug impregnation at 80 than 200 bar. It is well known
that co-solvent such as ethanol promotes the solubility of polar
drugs in CO2 by enhancing the overall polarity of the ﬂuid phase.
Furthermore, the CO2 sorption and swelling/plasticizing can also
increase with the addition of a co-solvent if polymer/CO2/co-
solvent interactions are favored (Costa et al., 2010b; Masmoudi
et al., 2011). An absence of any further drug impregnation at higher
pressure in the presence of ethanol could be either due to the
saturation of IOLs or lack of improvement in polymer/drug
interactions.
Interestingly, impregnation yields were comparable for sam-
ples processed with ethanol (at 80 and 200 bar) and only scCO2 at
200 bar (without ethanol). Hence, CIP loading was performed
without the use of co-solvent from hereon which is also preferable
for the intended application
In vitro drug release from impregnated IOLs was conducted for
60 days for both diopters (+5.0 and +21.0 D). The release kinetics
from CIP loaded IOLs is illustrated in Fig. 7 (+5.0 D) and which
suggests in-depth (absence of surface adsorption) and homoge-
neous impregnation of the drug in IOLs.
Release proﬁles discussed above were ﬁtted with Eq. (2) and the
ﬁtting parameters obtained for both diopters (+5.0 and +21.0 D) are
summarized in Table 6.
For all the experiments, the exponent value (n) is ranging
between 0.5 and 1.0 which suggests that the drug release is
occurred by an anomalous transport type (i.e., the superimposition
of Fickian controlled and swelling controlled release) (Ritger and
Peppas, 1987a,b).
The release rate constant (k) decreased as the impregnation
pressure increased or when a co-solvent was used. This indicates
that the afﬁnity between P-HEMA IOLs and CIP increases with the
increase in pressure or the addition of a co-solvent (Yañez et al.,
2011). A regression coefﬁcient of higher than 96% indicates that the
model currently used ﬁts well with drug release proﬁles. Release
exponents were similar for IOLs impregnated in different
conditions for both diopters.
3.3.1.2. Experimental design. Following the results of the ﬁrst
series of experiments, it could be concluded that drug loadings
were signiﬁcantly inﬂuenced by the change in pressure in the
absence of a co-solvent. Moreover, increase in pressure in the
presence of co-solvent had minimal inﬂuence on the impregnation
yield. Therefore, a response surface methodology based on
experimental design was used to study the inﬂuence of
Fig. 6. Inﬂuence of the pressurization rate (250 g h1) on the visual aspect of IOLs treated with scCO2; (a) in the presence of ethanol (5%); (b) in the absence of co-solvent.
Table 5
Tg of P-HEMA IOLs drying in an oven and with scCO2.
Drying mode Drying conditions Tg (C)  0.3
Oven 40 C 113
Oven 90 C 121
ScCO2 80 bar and 35 C, 30 min 119
ScCO2 140 bar and 35 C, 135 min 121
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operating conditions on the impregnation of CIP on +21.0 D IOLs.
Two entry values with 5 levels each were considered; pressure
(80–200 bar) and impregnation duration (30–240 min).
The operational conditions and results from these experiments
are summarized in Table 7. All impregnations were carried out at
35 C with a CO2 ﬂow rate of 250 g h
1 and a depressurization rate
of 2 bar min1 without the use of co-solvent.
For the different experimental conditions, impregnated
amounts ranged between 21 and 67 mg which suggests that the
studied factors have noteworthy inﬂuence on the response surface.
Fig. 9 presents release kinetics of CIP impregnated samples
prepared at different pressures and durations.
The drug release was dependent on the mass of impregnated
CIP in IOLs at various conditions. For example, a sustained release
Table 6
Impregnation rates and kinetics parameters of IOLs of +5.0 D and +21.0 D diopters (at 35 C and 2 h), determined by drug release studies.






















n k R2 n k R2
Without co-solvent
80 11.9 11  0.2 0.9  0.1 20 0.835 0.072 0.995 20.1 20  0.2 0.9  0.1 20 0.748 0.076 0.972
200 11.3 39  0.5 3.4  0.5 40 0.907 0.043 0.962 20.6 59  0.5 2.9  0.3 40 0.810 0.058 0.975
With co-solvent
80 11.5 44  0.6 3.8  0.6 40 0.866 0.052 0.987 20.5 61  0.5 3.0  0.3 40 0.842 0.052 0.997
200 11.4 47  0.6 4.1  0.6 40 0.884 0.050 0.994 20.3 65  0.5 3.2  0.3 40 0.794 0.065 0.965
a Initial mass of the dry IOL before impregnation.
Fig. 7. Accumulated drug release from IOLs (+5.0 D) impregnated at 35 C with the pressurization rate of 250 g h1, impregnation duration of 2 h and depressurization rate of
2 bar min1.
Table 7
Experimental design conditions, impregnation rates and kinetics parameters of IOLs (+21.0 D) impregnated at 35 C.
P (bar) timp (x1) (min) m0IOL (mg) mCIP imp (mg) yimp (mgdrug/mgIOL) trelease (days) Kinetics parameters
n k R2
100 60 19.0 26  0.2 1.4  0.1 18 0.555 0.133 0.977
100 210 18.6 30  0.3 1.6  0.1 40 0.837 0.039 0.987
180 60 18.9 39  0.3 2.1  0.2 30 0.685 0.090 0.981
180 210 19.5 53  0.4 2.7  0.2 40 0.772 0.058 0.991
140 30 19.2 22  0.1 1.1  0.1 18 0.727 0.061 0.985
140 240 20.0 41  0.3 2.1 0.1 45 0.982 0.031 0.991
80 135 19.1 21  0.2 1.1  0.1 10 0.859 0.307 0.992
200 135 19.5 67  0.4 3.4  0.2 45 0.839 0.053 0.989
140 135 19.0 33  0.2 1.7  0.1 20 0.894 0.123 0.972
140 135 18.8 35  0.1 1.7  0.1 20 0.555 0.133 0.977
140 135 18.8 31  0.1 1.6  0.1 20 0.837 0.039 0.987
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ranging from 10 to 30 days was obtained for IOLs impregnated at
100 bar/60 min, 180 bar/60 min, 140 bar/30 min, 80 bar/135 min
and 140 bar/135 min. Whereas, samples with higher impregnation
yields (impregnated at 100 bar/210 min, 180 bar/210 min, 140 bar/
240 min and 200 bar/135 min) showed drug release for signiﬁ-
cantly longer durations (40–45 days).
Fig. 10 presents examples of samples prepared at 140 and
180 bar to explain the effect of impregnation duration on release
kinetics. It is interesting to note that the drug release is always
higher and extended for samples prepared with longer impregna-
tion durations at a given pressure even when slopes do not appear
signiﬁcantly dissimilar. Therefore, it can be concluded that
increasing the impregnation time allows a more in-depth diffusion
of the drug facilitated by the improved swelling of the polymer.
Release proﬁles were ﬁtted to Eq. (2) to obtain release
exponents for impregnated IOLs similar to the preliminary
experiments. The ﬁtting parameters obtained for IOL samples
are summarized in Fig. 7.
Similar to preliminary experiments, release exponents ranging
between 0.5 and 1 conﬁrm drug release to occur by an anomalous
transport type (i.e., the superimposition of Fickian controlled and
swelling controlled release). The impregnated amounts obtained
from release proﬁles were used to calculate an impregnation
model by multilinear regression. The model coefﬁcients are
presented in Eq. (4) and a regression coefﬁcient (R2) of
0.945 suggests that this model can be considered as reliable tool
to predict changes in impregnated amounts within the studied
operating conditions.






Fig. 11 shows the impregnated amount predicted by the RSM
model as a function of pressure and impregnation duration.
A high variation of response in terms of drug loading in IOLs
with the pressure increase is evident in Fig. 11. This is expected due
to improved drug solubility and swelling/plasticization of poly-
mers in scCO2 at higher pressures (Champeau et al., 2015a,b; Yu
et al., 2011; Duarte et al., 2008; Ritger and Peppas, 1987b; Costa
et al., 2010a). The effect of impregnation duration is minimal at low
pressures but signiﬁcant at pressures above 140 bar. A direct
Fig. 8. Accumulated drug release from IOLs (+21.0 D) impregnated at 35 C with the pressurization rate of 250 g h1, impregnation duration of 2 h and depressurization rate of
2 bar min1.
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Fig. 9. Accumulated drug release from IOLs (+21.0 D) impregnated, using experimental design, at 35 C, pressurization rate of 250 g h1, without co-solvent and
depressurization rate of 2 bar min1.
Fig. 10. Accumulated drug release from IOLs (+21.0 D) impregnated, using experimental design, at (a) 140 bar, (b) 180 bar.
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impact of increase in processing time on drug impregnation at
higher pressures is apparent in Fig. 11. This could also be attributed
to higher CO2 sorption resulting in polymer swelling and improved
dissolution of CIP. In other words, it could be suggested that
thermodynamic equilibrium was not reached at low impregnation
durations.
The lowest drug loading of 21 mg was obtained on samples
processed at 80 bar for 135 min whilst highest drug loading (67 mg)
was achieved at 200 bar for the same duration. 80 and 200 bar were
the lowest and highest pressures studied in this work and response
surface clearly shows high pressure as the key factor for efﬁcient
drug impregnation in IOLs.
3.3.2. Dexamethasone 21-phosphate disodium impregnation
It is well known that the efﬁciency of the supercritical
impregnation is not only dependent on the employed operational
conditions but also on the physico-chemical interactions between
all involved substances in the process. The supercritical impreg-
nation of DXP on P-HEMA IOLs was carried out at various
conditions similar to CIP. The inﬂuence of pressure (80 and
200 bar) and use of a co-solvent (5 mol% ethanol) on drug
impregnation was studied for diopters +21.0 and +32.0 D. Other
parameters i.e., temperature (35 C), impregnation duration (2 h),
pressurization (250 g h1) and depressurization rates (2 bar min1)
were kept constant for all experiments.
The experimental conditions and impregnation yields for DXP
loading are summarized in Fig. 8.
Impregnation yields obtained at the different experimental
conditions were comparable and reproducible for both diopters.
The increase in pressure from 80 to 200 bar had no signiﬁcant
effect on the amount of DXP impregnated in IOLs. However, higher
impregnation yield was obtained upon the addition of ethanol in
the processing media. The increase in pressure for samples
processed with co-solvent showed minimal improvement in the
drug loading.
These results strongly suggest that the use of co-solvent is
favorable toward DXP impregnation. However, residual solvent can
be a concern for ocular implants. Hence, NMR analyses were
carried out on DXP impregnated (without and with washing step
before depressurization) IOLs to determine the presence of
Fig. 11. A two-dimensional contour plot and a three-dimensional response surface of impregnated mass (mg) illustrating optimal conditions for the supercritical
impregnation of P-HEMA IOLs with CIP.
Fig. 12. Drug released (%) from IOLs (+21.0 D) impregnated at 35 C, pressurization rate of 250 g h1, impregnation duration of 2 h and depressurization rate of 2 bar min1.
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ethanol. Ethanol peaks disappears when a supplementary CO2
washing step is performed indicating a residual solvent content to
be lower than 0.01 wt% of ethanol in the IOLs.
The DXP release from impregnated IOLs is presented in Fig. 12
(in function of the % drug released which is deﬁned as a ratio
between different cumulative released amounts and the ﬁnal
constant one obtained while reaching the release plateau) and
Fig. 13 (in function of the cumulative drug released) for both +21.0
and +32.0 D diopters, respectively.
Samples prepared at both pressures and with or without co-
solvent exhibited same release proﬁle without any burst release.
Similar to CIP samples, this indicates in-depth and homogenous
impregnation of DXP within P-HEMA IOLs.
Release proﬁles of DXP were ﬁtted to Eq. (2) and the release
parameters are presented in Table 8.
The regression coefﬁcients of more than 93% was obtained for
both diopters prepared at discussed conditions. Furthermore,
similar release exponents for the impregnated IOLs suggest DXP
release to also occur by an anomalous transport type.
4. Conclusion
IOLs have proven signiﬁcance in the ﬁeld of therapeutics (Aqil
and Gupta, 2012), their development is an upcoming route for
ocular drug delivery. This work was aimed at developing drug
impregnated foldable intraocular lenses (P-HEMA) in order to
combine cataract surgery and postoperative treatment in a single
procedure. Two commonly used drugs, ciproﬂoxacin and dexa-
methasone 21-phosphate disodium to prevent cataract postoper-
ative complications were studied in this work.
The supercritical impregnation was carried out in a batch mode
and the impregnated yields were determined by drug release
studies. This work underlines the importance of coupling slow
pressurization and depressurization during supercritical treat-
ment of P-HEMA IOLs in order to avoid the appearance of
undesirable foaming. A pressurization rate of 250 g h1 accompa-
nied by depressurization at 2 bar min1 was optimum to maintain
the optical properties of IOLs. A pretreatment step to remove
adsorbed ﬂuid on P-HEMA lenses was carried out using two
different methods; oven and scCO2. DSC analyses of IOLs dried in
an oven at 90 C and with scCO2 at 40 C and 140 bar for 135 min
showed same Tg (121 C) conﬁrming complete removal of water.
CIP and DXP impregnation was performed at a range of
pressures and temperatures in scCO2 to study the effect of these
parameters on impregnation yield. For P-HEMA/CIP system,
supercritical impregnations were initially carried out at pressures
80 and 200 bar in the presence or absence of ethanol as a co-
solvent for two diopters (+5.0 D and +21.0 D). Drug loading
enhancement with the pressure was observed in the absence of
co-solvent for both diopters. Whereas, addition of co-solvent had
no further improvement in the impregnation yield of CIP.
Following the results of the ﬁrst series of experiments and
according to the aimed application, a response surface methodol-
ogy based on experimental designs was applied to study the
Table 8
Impregnation rates and kinetics parameters of IOLs of +21.0 D and +32.0 D diopters (at 35 C and 2 h), determined by drug release studies (40 days of release).


















n k R2 n k R2
Without co-solvent
80 19.4 165  24 8.5  1.3 0.842 0.058 0.967 20.1 171  25 8.5  1.3 0.919 0.044 0.962
200 20.0 182  27 9.1  1.4 0.781 0.099 0.954 20.5 191  28 9.3  1.4 0.790 0.077 0.931
With co-solvent
80 19.0 247  37 13.1  2.0 0.763 0.080 0.942 20.2 266  39 13.2  2.0 0.791 0.098 0.934
200 19.5 270  40 13.8  2.1 0.733 0.072 0.946 20.3 295  43 14.5  2.2 0.929 0.038 0.944
a Initial mass of the dry IOL before impregnation.
Fig. 13. Accumulated drug release from IOLs (+32.0 D) impregnated at 35 C, pressurization rate of 250 g h1, impregnation duration of 2 h and depressurization rate of
2 bar min1.
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inﬂuence of operating conditions on impregnation in the absence
of a co-solvent. Two input variables were considered; pressure
(80–200 bar) and impregnation duration (30–240 min). The CIP
impregnation ranging between 1.10 and 3.44 mg/mg was obtained
from these experiments. The response surface indicated pressure
to be the governing factor in impregnation where increase in
pressure promoted drug loading. The effect of impregnation
duration on CIP loading was only evident at relatively high
pressures (>140 bar).
Similarly, inﬂuence of pressure (80 and 200 bar) and co-solvent
was also studied for the P-HEMA/DXP system. Unlike CIP, use of
ethanol (5 mol%) as a co-solvent improves DXP impregnation in
IOLs. The DXP loading involved addition of an extra washing step to
ensure complete removal of ethanol from P-HEMA IOLs. The NMR
analysis was performed on drug impregnated lenses which did not
show any presence of residual solvent.
The highest impregnation yields for DXP and CIP in P-HEMA
lenses were 14.53 and 4.12 mg/mgIOL respectively. This indicates
higher afﬁnity of DXP for P-HEMA IOLs than CIP. This study
provides important information on the impregnation of two
commonly used drugs in the complications related to cataract
surgery on P-HEMA IOLs which could be used to carry out
simultaneous loading of both drugs in the future.
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